康辰药业[.SH]2023年度暨2024年季度业绩说明会

Summary of the Conference Call Company Overview - The conference call is regarding Kangcheng Pharmaceutical's 2023 annual and Q1 2024 performance briefing [1] Key Points Discussed - The meeting was led by the company's Chief Financial Officer and Board Secretary, Sun Yuping, who introduced key attendees including Chairman Liu Jianhua, President Niu Zanqi, and Independent Director Li Hongyi [1] Additional Important Information - The presence of high-level executives indicates a focus on transparency and engagement with stakeholders [1]